Chemical Compound
(4S)-4-Cyclohexyl-1-[[hydroxy(4-phenylbutyl)phosphinyl]acetyl]-L-proline; trans-4-Cyclohexyl-1-[[hydroxy(4-phenylbutyl)phosphinyl]acetyl]-L-proline; Fosinopril impurity A; (2S,4S)-4-cyclohexyl-1-[[(R)-hydroxy(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid; USP Fosinopril Related Compound A; SQ-27519; (4S)-4-cyclohexyl-[(4-phenylbutyl)phosphinyl]acetyl-L-proline; Fosinopril Related Compound A; Fosinopril Sodium Impurity A; Fosinopril Impurity A
CAS Registry Number
95399-71-6
Primary record
(4S)-4-Cyclohexyl-1-[[hydroxy(4-phenylbutyl)phosphinyl]acetyl]-L-proline; trans-4-Cyclohexyl-1-[[hydroxy(4-phenylbutyl)phosphinyl]acetyl]-L-proline; Fosinopril impurity A; (2S,4S)-4-cyclohexyl-1-[[(R)-hydroxy(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid; USP Fosinopril Related Compound A; SQ-27519; (4S)-4-cyclohexyl-[(4-phenylbutyl)phosphinyl]acetyl-L-proline; Fosinopril Related Compound A; Fosinopril Sodium Impurity A; Fosinopril Impurity A
- 库存
- 7,016 克
- 纯度
- 99.4 %
- CAS
- 95399-71-6
化合物标识与属性
- CAS
- 95399-71-6
- PubChem CID
- 62956
- SMILES
- C1CCC(CC1)[C@@H]2C[C@H](N(C2)C(=O)CP(=O)(CCCCC3=CC=CC=C3)O)C(=O)O
- Canonical SMILES
- O=C(O)[C@@H]1C[C@@H](C2CCCCC2)CN1C(=O)CP(=O)(O)CCCCc1ccccc1
名称与同义词
- Fosinoprilat
- fosfenopril
- Fosinopril diacid
- Fosinoprilic acid
- Fosinoprilatum
- Forsinoprilat
- Fospenopril
- fosinopril impurity a
- 95399-71-6
- Fosinoprilat Disodium
- PU6BA2D2MD
- Fosinoprilat [USAN:INN]
- Fosinoprilatum [INN-Latin]
- CHEMBL581
- RefChem:57081
- S312EY6ZT8
- UNII-S312EY6ZT8
- Fosinopril impurity A CRS
- Fosinopril Related Compound A
- Fosinoprilat (USAN/INN)
- FOSINOPRILAT [INN]
- FOSINOPRILAT [USAN]
- AC1L1Y3Y
- C23H34NO5P
- SQ-27519
- SQ 27,519
- SCHEMBL124537
- SCHEMBL677955
- CHEBI:116962
- DTXSID80869253
- FOSINOPRIL DIACID [MI]
- WOIWWYDXDVSWAZ-RTWAWAEBSA-N
- GTPL6457
- FOSINOPRIL EP IMPURITY A
- Fosinopril sodium EP Impurity A
- DTXCID60820726
- SO-27519
- CID62956
- ZINC4213382
- C23-H34-N-O5-P
- BDBM50018849
- AKOS032953851
- DB14207
- SQ-27,519
- DA-63591
- SQ 27519
- (4S)-4-Cyclohexyl-1-((hydroxy(4-phenylbutyl)phosphinyl)acetyl)-L-proline
- HY-107352
- J261.896F
- LS-178257
- SO 27,519
- CS-0028200
- L-Proline, 4-cyclohexyl-1-[[hydroxy(4-phenylbutyl)phosphinyl]acetyl]-,(4S)-
- NS00126388
- C21542
- D03772
- FOSINOPRIL RELATED COMPOUND A [USP-RS]
- G76770
- A929501
- FOSINOPRIL SODIUM IMPURITY A [EP IMPURITY]
- FOSINOPRIL RELATED COMPOUND A [USP IMPURITY]
- L-Proline, 4-cyclohexyl-1-((hydroxy(4-phenylbutyl)phosphinyl)acetyl)-, trans-
- (2S,4S)-4-cyclohexyl-1-(2-(hydroxy(4-phenylbutyl)phosphoryl)acetyl)pyrrolidine-2-carboxylic acid
- (2S,4S)-4-cyclohexyl-1-{2-[hydroxy(4-phenylbutyl)phosphoryl]acetyl}pyrrolidine-2-carboxylic acid
- BRD-A33506612-001-01-2
- Q27077720
- (4S)-4-Cyclohexyl-[(4-phenylbutyl)phosphinyl]acetyl-L-proline
- (4S)-4-cyclohexyl-1-{[hydroxy(4-phenylbutyl)phosphoryl]acetyl}-L-proline
- 4-Cyclohexyl-1-{2-[hydroxy-(4-phenyl-butyl)-phosphinoyl]-acetyl}-pyrrolidine-2-carboxylic acid
- B1370-301422
- (2S,4S)-4-cyclohexyl-1-[2-[hydroxy(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid
- (2S,4S)-4-cyclohexyl-1-{2-[hydroxy-(4-phenyl-butyl)-phosphinoyl]-acetyl}-pyrrolidine-2-carboxylic acid
- (4S)-4-cyclohexyl-1-((hydroxy(4-phenylbutyl)phosphoryl)acetyl)-L-proline
- 1[{hydroxy(4-phenylbutyl)phosphinyl}acetyl]-(trans)-4-cyclohexyl-l-proline
- 4beta-Cyclohexyl-1-[[hydroxy(4-phenylbutyl)phosphinyl]acetyl]-L-proline
- trans-4-cyclohexyl-1-[[hydroxy(4-phenylbutyl)phosphinyl]acetyl]-l-proline
- L-Proline, 4-cyclohexyl-1-[[hydroxy(4-phenylbutyl)phosphinyl]acetyl]-, (4S)-
- L-Proline,4-cyclohexyl-1-[2-[hydroxy(4-phenylbutyl)phosphinyl]acetyl]-,(4S)-
- (2S,4S)-4-CYCLOHEXYL-1-((HYDROXY(4-PHENYLBUTYL)PHOSPHORYL)ACETYL)PYRROLIDINE-2-CARBOXYLIC ACID
- (2S,4S)-4-cyclohexyl-1-(2-(hydroxy-(4-phenylbutyl)phosphoryl)acetyl)pyrrolidine-2-carboxylic acid
- (2S,4S)-4-cyclohexyl-1-[2-(hydroxy-(4-phenylbutyl)phosphoryl)acetyl]pyrrolidine-2-carboxylic acid
- (4S)-4-Cyclohexyl-1-[[hydroxy(4-phenylbutyl)phosphinyl]acetyl]-L-proline; trans-4-Cyclohexyl-1-[[hydroxy(4-phenylbutyl)phosphinyl]acetyl]-L-proline; Fosinopril impurity A; (2S,4S)-4-cyclohexyl-1-[[(R)-hydroxy(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid; USP Fosinopril Related Compound A; SQ-27519; (4S)-4-cyclohexyl-[(4-phenylbutyl)phosphinyl]acetyl-L-proline; Fosinopril Related Compound A; Fosinopril Sodium Impurity A; Fosinopril Impurity A
- 110-994-9
- KS8